Swiss National Bank
ARCT icon

Swiss National Bank’s Arcturus Therapeutics ARCT Stock Holding History

Swiss National Bank’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-47,700
Closed -$505K – 2338
2025
Q1 		$505K Hold
47,700
– – ﹤0.01% 2337
2024
Q4 		$809K Hold
47,700
– – ﹤0.01% 2292
2024
Q3 		$1.11M Hold
47,700
– – ﹤0.01% 2170
2024
Q2 		$1.16M Buy
47,700
+500
+1% +$15.2K ﹤0.01% 2105
2024
Q1 		$1.59M Hold
47,200
– – ﹤0.01% 1964
2023
Q4 		$1.49M Sell
47,200
-5,400
-10% -$128K ﹤0.01% 2010
2023
Q3 		$1.34M Buy
52,600
+500
+1% +$15.4K ﹤0.01% 2077
2023
Q2 		$1.49M Buy
52,100
+700
+1% +$19.1K ﹤0.01% 2075
2023
Q1 		$1.23M Sell
51,400
-6,300
-11% -$113K ﹤0.01% 2128
2022
Q4 		$979K Buy
57,700
+1,800
+3% +$31.4K ﹤0.01% 2357
2022
Q3 		$828K Hold
55,900
– – ﹤0.01% 2419
2022
Q2 		$880K Buy
55,900
+6,000
+12% +$118K ﹤0.01% 2438
2022
Q1 		$1.34M Buy
49,900
+3,600
+8% +$91.9K ﹤0.01% 2257
2021
Q4 		$1.71M Hold
46,300
– – ﹤0.01% 2164
2021
Q3 		$2.21M Hold
46,300
– – ﹤0.01% 1992
2021
Q2 		$1.57M Buy
46,300
+1,500
+3% +$50.8K ﹤0.01% 2257
2021
Q1 		$1.85M Buy
44,800
+700
+2% +$41.7K ﹤0.01% 2044
2020
Q4 		$1.91M Buy
44,100
+800
+2% +$54.2K ﹤0.01% 1929
2020
Q3 		$1.86M Buy
43,300
+10,000
+30% +$496K ﹤0.01% 1759
2020
Q2 		$1.56M Buy
+33,300
New +$1.15M ﹤0.01% 1850

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Swiss National Bank's ARCT Position: Q2 2025 in Review

Swiss National Bank sold out of Arcturus Therapeutics (ARCT) in Q2 2025, closing a stake of 47,700 shares — an estimated $505K sold.

Swiss National Bank first reported a position in ARCT in Q2 2020 and held it in 20 quarters. The position peaked at $2.21M in Q3 2021. 143 funds tracked by Wall St. Rank hold ARCT as of Q2 2025.

  • Swiss National Bank reported no remaining Arcturus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Swiss National Bank sold 47,700 Arcturus Therapeutics shares in Q2 2025, an estimated $505K.
  • Swiss National Bank first reported a position in Arcturus Therapeutics in Q2 2020 and held it in 20 quarters.
  • Swiss National Bank's Arcturus Therapeutics position peaked at $2.21M in Q3 2021.
  • 143 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2025.

Based on Swiss National Bank's 13F filing for Q2 2025, filed 12 Aug 2025.